ADVM
Adverum Biotechnologies
Adverum Biotechnologies is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Company Sector
Ophthalmology
23 companies tagged with Ophthalmology.
Ophthalmology includes companies developing therapies, devices, and diagnostics for diseases of the eye, including retinal disorders, glaucoma, dry eye, and surgical vision care. This page groups businesses exposed to both therapeutic and procedure-driven eye care markets.
ALC
Alcon Inc.
Alcon is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ALIM
Alimera Sciences
Alimera Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
AURA
Aura Biosciences
Aura Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CARM
Carisma Therapeutics, Inc.
Carisma Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
EYEN
Eyenovia
Eyenovia is an ophthalmology-focused biopharmaceutical company centered on eye-disease programs where clinical validation and specialty adoption drive the narrative.
EYPT
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals is an ophthalmology-focused biopharmaceutical company centered on eye-disease programs where clinical validation and specialty adoption drive the narrative.
GKOS
Glaukos Corporation
Glaukos is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
GRAY
Graybug
Graybug is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
GHSI
Guardion Health Sciences
Guardion Health Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
HROW
Harrow, Inc.
Harrow is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
IRIX
IRIDEX
IRIDEX is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
KALA
KALA BIO
KALA BIO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
EYE
National Vision
National Vision is an ophthalmology-focused biopharmaceutical company centered on eye-disease programs where clinical validation and specialty adoption drive the narrative.
NBY
Novabay Pharmaceuticals
Novabay Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NVS
Novartis AG
Novartis AG is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
OCGN
Ocugen
Ocugen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
OCUL
Ocular Therapeutix
Ocular Therapeutix is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
OCS
Oculis
Oculis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
OKYO
OKYO Pharma
OKYO Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
OYST
Oyster Point
Oyster Point is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SGHT
Sight Sciences
Sight Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
TARS
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.